Peter J. Weiler's most recent trade in Edesa Biotech Inc was a trade of 64,609 Common Shares done . Disclosure was reported to the exchange on May 27, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edesa Biotech Inc | Peter J. Weiler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 64,609 | 129,609 (1%) | 0% | 0 | Common Shares | |
| Edesa Biotech Inc | Peter J. Weiler | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 65,000 | 65,000 (0%) | 0% | 0 | Common Shares |